Reliability and validity of the CogState battery Chinese language version in schizophrenia
Background: Cognitive impairment in patients with schizophrenia is a core symptom of this disease. The computerized CogState Battery (CSB) has been used to detect seven of the most common cognitive domains in schizophrenia. The aim of […]
A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer’s disease
Introduction: Histaminergic H3 receptors may play a role in modulating cholinergic and monoaminergic neurotransmission. This Phase II study evaluated the efficacy and safety of GSK239512, a highly potent, brain penetrant H3 receptor antagonist as monotherapy treatment […]
Prospective associations between dietary patterns and cognitive performance during adolescence
Background: The aim of the study was to investigate prospective associations between dietary patterns and cognitive performance during adolescence. Methods: Participants were sourced from the Western Australian Pregnancy Cohort (Raine) Study that includes 2868 children born […]
Birth Weight and Cognitive Function in Early Adulthood: The Australian Aboriginal Birth Cohort Study
It has been suggested that in addition to genetic factors, fetal and post-natal growth influence cognition in early adulthood. However, most studies have been in developed populations, so it is unclear if the same findings would […]
Computerized Neurocognitive Test (CNT) in Mild Cognitive Impairment and Alzheimer’s Disease
Currently, computerized batteries are of great value in detecting cognitive impairment. This aim of this review was to compare the computerized neurocognitive batteries used in most studies with cognitive decline over the last 10 years. Using […]
